AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
10.50
+0.31 (3.04%)
Aug 8, 2022 4:00 PM EDT - Market closed
Total Valuation
ANTX has a market cap or net worth of $203.73 million. The enterprise value is $85.41 million.
| Market Cap | 203.73M |
| Enterprise Value | 85.41M |
Important Dates
The next earnings date is Tuesday, August 9, 2022, before market open.
| Estimated Earnings Date | Aug 9, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
ANTX has 19.40 million shares outstanding.
| Shares Outstanding | 19.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +20.56% |
| Owned by Insiders (%) | 10.02% |
| Owned by Institutions (%) | 47.52% |
| Float | 5.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.55, with a Debt / Equity ratio of 0.00.
| Current Ratio | 23.55 |
| Quick Ratio | 23.27 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.58M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | -30.00% |
| 50-Day Moving Average | 8.42 |
| 200-Day Moving Average | 12.05 |
| Average Volume (30 Days) | 64,093 |
Short Selling Information
The latest short interest is 185,326, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 185,326 |
| Short % of Shares Out | 0.96% |
| Short % of Float | 3.36% |
| Short Ratio (days to cover) | 2.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Net Income | -34.72M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | -$12.50 |
Balance Sheet
The company has $118.35 million in cash and $32,000 in debt, giving a net cash position of $118.32 million or $6.10 per share.
| Cash & Cash Equivalents | 118.35M |
| Total Debt | 32,000 |
| Net Cash | 118.32M |
| Net Cash Per Share | $6.10 |
| Book Value | 115.41M |
| Book Value Per Share | 5.95 |
| Working Capital | 114.70M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -17.04% |
| FCF Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
The average price target for ANTX is $25.16, which is 139.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $25.16 |
| Price Target Difference | 139.62% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |